Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for tracheal intubation in children
ChiCTR2500115753Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: ED90 of oliceridine inhibiting cardiovascular response to endotracheal intubation. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
oliceridine
Beyond the preview
Go deeper on ChiCTR2500115753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115753.